ELI LILLY AND COMPANY

(LLY)
  Report
Delayed Nyse  -  04:03 2022-08-15 pm EDT
313.94 USD   +1.90%
08/12ELI LILLY AND COMPANY : Ex-dividend day for
FA
08/11First Patient Dosed in ALX Oncology's Mid-Stage Trial of Colorectal Cancer Combination Therapy
MT
08/11Lilly Announces Leadership Transition in Human Resources and New Chief Commercial Officer for Loxo@Lilly
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on ELI LILLY AND COMPANY
Target Price consensus revisions : last 18 months
Recommendations (Chart) ELI LILLY AND COMPANY
Analyst Recommendations on ELI LILLY AND COMPANY
08/05Goldman Sachs Adjusts Price Target for Eli Lilly and Company to $273 From $277, Maintains ..
MT
08/04Cantor Fitzgerald Raises Price Target for Eli Lilly and Company to $360 From $335, Maintai..
MT
07/13Goldman Sachs Raises Eli Lilly and Company's Price Target to $277 From $276, Maintains Neu..
MT
07/12ANALYST RECOMMENDATIONS : Blackrock, Eli Lilly, Hammerson, Mondelez, Twitter...
MS
07/11Guggenheim Raises Price Target for Eli Lilly and Company to $351 From $333, Maintains Buy ..
MT
07/08Morgan Stanley Adjusts Eli Lilly's Price Target to $395 From $369, Reiterates Overweight R..
MT
07/07Barclays Adjusts Eli Lilly and Co.'s Price Target to $355 From $333, Keeps Overweight Rati..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 313,94 $
Average target price 327,10 $
Spread / Average Target 4,19%
High Price Target 395,00 $
Spread / Highest target 25,8%
Low Price Target 202,00 $
Spread / Lowest Target -35,7%
Consensus detail
Consensus revision (last 18 months)